Drug
Riviciclib clinical trials
Also written P276-00.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Other names
- P276-00
- 10
Studies by the year they started
10 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses riviciclib is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00CompletedPhase 2Piramal Enterprises LimitedNCT01903018Written as P276-00
- A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck CancerCompletedPhase 2Piramal Enterprises LimitedNCT00824343Written as P276-00
- Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 ExpressionCompletedPhase 2Piramal Enterprises LimitedNCT00835419Written as P276-00
- Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck CancerCompletedPhase 1/2Piramal Enterprises LimitedNCT00899054Written as P276-00
- Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple MyelomaCompletedPhase 1/2Piramal Enterprises LimitedNCT00882063Written as P276-00
- A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell LymphomaTerminatedPhase 2Piramal Enterprises LimitedNCT00843050Written as P276-00
- Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic CancerCompletedPhase 1/2Piramal Enterprises LimitedNCT00898287Written as P276-00
- Phase I Study for Safety and Efficacy of P276-00 in Subjects With MyelomaWithdrawnPhase 1Piramal Enterprises LimitedNCT00547404Written as P276-00
- Open Label Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsCompletedPhase 1Piramal Enterprises LimitedNCT00407498Written as P276-00
- Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsTerminatedPhase 1Piramal Enterprises LimitedNCT00408018Written as P276-00
Codes
What other systems call riviciclib · ClinicalTrials.gg INT005096
- UNII (FDA) DRP53ZDY6HRIVICICLIB HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27276566riviciclib hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C141429Riviciclib HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | DRP53ZDY6H | RIVICICLIB HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27276566 | riviciclib hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C141429 | Riviciclib Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.